Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 785 | 1,490 | 4,315 | 3,375 | 2,425 |
| Gross Profit | 785 | 1,490 | 4,315 | 3,375 | 2,425 |
| Operating Expenses | 42,499 | 46,437 | 35,681 | 20,917 | 35,533 |
| Operating Income | -41,714 | -44,947 | -31,366 | -17,542 | -33,108 |
| Other Income | 2,235 | 777 | 33 | 317 | -1,080 |
| Pre-tax Income | -39,479 | -44,170 | -31,333 | -17,225 | -34,188 |
| Net Income Continuous | -39,479 | -44,170 | -31,333 | -17,225 | -34,188 |
| Net Income | $-39,479 | $-44,170 | $-31,333 | $-17,225 | $-34,188 |
| EPS Basic Total Ops | -13.43 | -16.80 | -12.80 | -17.00 | -66.20 |
| EPS Basic Continuous Ops | -13.43 | -16.79 | -12.71 | -16.97 | -66.20 |
| EPS Diluted Total Ops | -13.43 | -16.80 | -12.80 | -17.00 | -66.20 |
| EPS Diluted Continuous Ops | -13.43 | -16.79 | -12.71 | -16.97 | -66.20 |
| EPS Diluted Before Non-Recurring Items | -13.43 | -16.80 | -12.80 | -17.00 | -31.20 |
| EBITDA(a) | $-43,347 | $-45,022 | $-31,366 | $-17,542 | $-33,108 |